The Finnish drug delivery technology company DelSiTech Ltd announced today that it is now able to provide high quality analytical services to its customers.

“We are extremely pleased of being able to serve our customers better”, said Lasse Leino, CEO of DelSiTech Ltd. “In-house analytical support means that we can run customer projects faster and more cost-effectively. Because we operate at non-GLP/GMP level, we can offer analytical services at reasonable price which is important in discovery and early stage development projects. We also welcome new customers with specific analytical needs.”